Future Outlook: Chemical Stock with 30% EBITDA Guidance and Strong Order Visibility

Synopsis: Navin Fluorine’s Q3 FY26 growth is driven by speciality chemicals, CDMO, and HPP segments, with a 30 percent EBITDA target supported by capacity expansions and strong order visibility.

This article outlines Navin Fluorine International Ltd’s Q3 FY26 performance, highlighting strong revenue and profit growth across HPP, speciality chemicals, and CDMO segments. It details strategic CAPEX, capacity expansions, and product pipeline developments, while providing outlook, operational highlights, and valuation insights, demonstrating the company’s multi-year growth potential.

Navin Fluorine International Ltd is an Indian chemical company that makes speciality chemicals, refrigerants, and fluorine-based products. Its products are used in industries like pharmaceuticals, agrochemicals, electronics, and refrigeration. The company focuses on high-value, export-oriented chemicals and has a strong presence in global markets.

With a market capitalization of Rs 32,834 crore, the shares of this company closed at Rs 6,407 per share, down by 2.48 percent from its previous close. The company trades at an overvalued P/E of 55.4x compared to its Industry P/E of 26.3x, and has returned 49 percent in the last year and 120 percent in the last five years.

Strong Revenue and Profit Growth

Navin Fluorine reported a strong Q3 FY26 performance with sales of Rs 892.4 crore, up 47 percent YoY and 18 percent QoQ. Operating EBITDA surged 109 percent YoY to Rs 307.6 crore, with margins expanding 1,017 bps YoY to 34.5 percent. Operating PBT rose 149 percent YoY to Rs 243.2 crore, while PAT climbed 122 percent YoY to Rs 185 crore, reflecting robust growth across segments.

Business Segment Performance

HPP Business: Navin Fluorine’s HPP vertical delivered strong performance in Q3 FY26, with revenue rising to Rs 412 crore, up 35 percent YoY from Rs 306 crore. Growth was driven by higher realisations and improved volumes amid a constructive pricing environment. The AHF project was successfully commissioned, and incremental HFC capacity of 15,000 MTPA R32 is on track for Q3 FY27.

Speciality Chemicals: The speciality chemicals segment achieved record quarterly revenue of Rs 354 crore in Q3 FY26, up 60 percent YoY from Rs 221 crore. Strong order visibility and a robust product pipeline, including scale-ups and new molecule launches, underpin a positive outlook. The Chemours Project and MPP de-bottlenecking at Dahej are on schedule for FY27, further strengthening capabilities.

CDMO & Advanced Materials: The CDMO business reported revenue of Rs 127 crore, up 61 percent YoY from Rs 79 crore, driven by strong execution and European customer traction. The cGMP-4 facility has commenced commercial supplies, providing three-year revenue visibility. In Advanced Materials, multiple projects in semiconductors and electronics are progressing, with ongoing evaluations to capture emerging opportunities in the value chain.

Strategic CAPEX Driving Growth Across Verticals

Navin Fluorine is advancing key CAPEX initiatives to drive growth across HFC, MPP, and Advanced Materials segments. The HFC expansion, adding up to 15,000 MTPA of R32, is backed by Rs. 236.5 crore internal funding and targets Q3 FY27 commissioning, with potential annual revenue of Rs 600–825 crore amid rising RAC demand and low-GWP transitions.

The MPP de-bottlenecking at Dahej, funded with Rs. 75 crore, supports a new molecule launch for a global innovator, expected by Q3 FY27, generating Rs 140 to 160 crore annually. Meanwhile, the Advanced Materials project, Rs. 120 crore with partial customer funding, aims to produce innovative liquid cooling products, expanding the company’s presence in high-growth emerging markets.

Outlook

Navin Fluorine’s speciality chemicals and CDMO segments are expected to sustain strong growth, with EBITDA margins targeted around 30 percent ± 2 percent annually. Full utilisation of new capacities, including AHF, cGMP-4, and R-32 expansion, is anticipated in FY27, unlocking incremental opportunities in electronics, semiconductors, and high-value fluorochemicals, supporting long-term earnings visibility.

Brokerage View: Prabhudas Liladhar

Valuation: Revenue, EBITDA, and PAT are expected to grow steadily through FY26–28, keeping the stock rated ‘Accumulate’ with a target price of Rs 7,038, based on 41x Dec’27E earnings.

Multiple Growth Levers: Navin Fluorine is set for strong multi-year growth, driven by a robust CDMO pipeline, expanding refrigerant capacities, and steady momentum in the agchem segment. The Chemours partnership, starting with USD14 mn, could scale up 10 times as demand for liquid cooling fluids rises.

Capacity Expansion & Product Diversification: Around 15,000 mtpa of R32-equivalent and 40,000 mtpa of AHF capacity will come online in FY27, boosting downstream integration and external sales. HFO volumes could grow 20 percent, and new collaborations, including with Honeywell, will reduce reliance on single products.

Speciality Chemicals & CDMO Ramp-Up: Project Nectar is expected to increase from 50 percent use in FY26 to around 75 percent by FY27 and full capacity in FY28. The CDMO pipeline of 10–15 molecules, with 2–3 nearing approvals, along with Fermion’s annual run-rate rising from USD40 mn, supports medium-term growth.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Future Outlook: Chemical Stock with 30% EBITDA Guidance and Strong Order Visibility appeared first on Trade Brains.